Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical-stage pipeline includes maveropepimut-S, which is in phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using its HapTenix neoantigen tumor cell construct platform for treating refractive late-stage ovarian cancer. The Company is also leveraging its expertise in tumor immunology by creating a unique library of T-lymphocytes and other datasets post-vaccination with its personalized immunotherapeutic vaccines to identify new targetable tumor antigens.


CSE:BIOV - Post by User

Post by moneywagonon Feb 08, 2022 9:22am
105 Views
Post# 34408020

BROKERS ALWAYS KNOW THE NEWS FIRST! LAST BI SHORT POSITION

BROKERS ALWAYS KNOW THE NEWS FIRST! LAST BI SHORT POSITIONLOOK SHORT chart......Dang Brokers have such an advantage on us minnows. Sheesh not one CEO can keep the news hush, never. You think that short position was not in the KNOW!!

Welll all good for those that have powder to seriously capitalize on this beast! lol
Those that are locked and loaded you are now up to date!
We count our ROI at the end of the year not in February. I will say when the bulls do eat they BITE IN CHUNKS.. ahhh duh with sp trading down here, you get quadruple the shares of past highs.

Short chart depicts last bi session BROKERS shorts knew that the pp was @15, dragged our sp close to pp. NOW LOOK shorts have disappeared...uhhh duh

Symbol Issue Name Shares Net Change Date
$BIOV.CN BIOVAXYS TECHNOLOGY CORP. 3,320 -130,546 31 Jan 2022
$BIOV.CN BIOVAXYS TECHNOLOGY CORP. 133,866 76,103 15 Jan 2022
$BIOV.CN BIOVAXYS TECHNOLOGY CORP. 57,763 -18,344 31 Dec 2021

<< Previous
Bullboard Posts
Next >>